MEIZHU CHEN: Open Payments
NPI 1770152969 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,356 in 69 payments from 25 companies in 2025. Trend: 2023 $0 · 2024 $2,327 · 2025 $2,356
Food & beverage: $2,095Education: $261
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $404 |
| Exelixis Inc. | 2 | $250 |
| Janssen Biotech, Inc. | 6 | $187 |
| Astellas Pharma US Inc | 7 | $176 |
| AstraZeneca Pharmaceuticals LP | 3 | $154 |
| Merck Sharp & Dohme LLC | 6 | $149 |
| Gilead Sciences, Inc. | 6 | $129 |
| Eisai Inc. | 5 | $118 |
| SEAGEN INC. | 1 | $100 |
| Stemline Therapeutics Inc. | 4 | $95 |
Products named: Enhertu, CABOMETYX, KEYTRUDA, Trodelvy, DATROWAY, IMFINZI, Lenvima, ERLEADA.
Industry payments across NY — which companies pay providers there.
